image
Krystal Biotech, Inc. KRYS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 170.74
-3.75 %
$ 4.91 B
Market Cap
96.46
P/E
CASH FLOW STATEMENT
-88.8 M OPERATING CASH FLOW
11.70%
Growth Rates
1Year 11.70%
3Years -50.44%
5Years -56.55%
7Years -82.62%
10Years 0.00%
82.6 M INVESTING CASH FLOW
172.44%
Growth Rates
1Year 172.44%
3Years 110.98%
5Years 58.51%
7Years 242.34%
10Years 0.00%
203 M FINANCING CASH FLOW
473.60%
Growth Rates
1Year 473.60%
3Years 19.77%
5Years 22.38%
7Years 80.49%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Krystal Biotech, Inc.
image
Net Income 10.9 M
Depreciation & Amortization 5.01 M
Capital Expenditures -11.8 M
Stock-Based Compensation 39.9 M
Change in Working Capital -37.9 M
Others -98.1 M
Free Cash Flow -101 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income 10.9 (140.0) (69.6) (32.2) (19.1) (10.9) (7.9) (1.1)
Depreciation & Amortization 5.0 4.1 2.8 1.9 0.7 0.1 23 K 2 K
Deferred Income Tax 0 0 0 0 0 0 0 0
Stock Based Compensation 39.9 33.2 15.3 3.3 1.2 0.8 0.2 33 K
Other Operating Activities (106.8) (0.7) 1.5 33 K 67 K 1.0 3.3 7 K
Change in Working Capital (37.9) 2.8 2.1 0.9 (1.7) 0.5 0.5 (0.2)
Cash From Operations (88.8) (100.6) (47.9) (26.1) (18.7) (9.4) (3.9) (1.3)
INVESTING CASH FLOW
Capital Expenditures (11.8) (53.0) (68.3) (14.8) (6.4) (2.2) (0.2) 15 K
Other Items 94.4 (61.1) (158.4) 3.7 1.4 (8.1) 0 0
Cash From Investing Activities 82.6 (114.1) (226.8) (11.2) (5.0) (10.3) (0.2) 15 K
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0 2.3 1.8
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities (0.7) (0.6) (8.0) 0 0 0 7.0 1.3
Cash From Financing Activities 202.8 35.3 347.7 118.0 107.5 73.8 51.8 3.2
CHANGE IN CASH
Net Change In Cash 196.4 (179.3) 73.0 80.8 83.8 54.1 47.7 1.9
FREE CASH FLOW
Free Cash Flow (100.6) (153.5) (116.3) (40.9) (25.1) (11.7) (4.1) (1.3)